Business Context and Reporting Period
This Form 8-K Current Report was filed by Inmune Bio, Inc. on May 7, 2025. The filing addresses a change in the company's independent registered public accounting firm. The company is incorporated in Nevada and its common stock trades on the NASDAQ under the symbol INMB.
Key Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the administrative change of auditors.
Material Changes
- Dismissal of Former Auditor: On May 7, 2025, the company dismissed Marcum LLP as its independent registered public accounting firm. This action was taken because Marcum's attest business was acquired by CBIZ CPAs P.C. on November 1, 2024.
- Engagement of New Auditor: On May 7, 2025, the company engaged CBIZ CPAs P.C. as its new independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Audit History: Marcum's audit reports for the fiscal years ended December 31, 2024, and 2023 did not contain adverse opinions or disclaimers. However, the reports included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
- Disagreements: There were no disagreements or reportable events between the company and Marcum regarding accounting principles, financial statement disclosures, or audit scope during the relevant periods.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on business outlook, or specific risk factors beyond the previously noted going concern qualification in prior audit reports. The transition of the audit firm is presented as a result of the acquisition of Marcum by CBIZ, with no indication of disputes or unusual items driving the change.
Investor Verification Checklist
- Verify the status of the "substantial doubt about going concern" noted in the 2023 and 2024 audit reports to assess current liquidity risks.
- Confirm the effective date of the new audit engagement with CBIZ CPAs for the 2025 fiscal year.
- Review the attached letter from Marcum LLP (Exhibit 16.1) to ensure no undisclosed disagreements exist.
- Monitor upcoming financial filings to see if the new auditor issues a modified opinion regarding the company's financial stability.